Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Prev Res (Phila). 2011 Mar;4(3):303-6. doi: 10.1158/1940-6207.CAPR-11-0053.

Challenges related to developing serum-based biomarkers for early ovarian cancer detection.

Author information

  • 1Clinical Genetics Branch,Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA.

Abstract

In this issue of the journal, Cramer and colleagues and Zhu and colleagues report carefully designed phase 3 assessments of candidate ovarian cancer screening biomarkers. The main conclusion is that CA-125 remains the "best of a bad lot"; the new candidates have fallen short of expectations. We review factors impeding the development of an effective ovarian cancer screening strategy, highlight the requirements related to validating proposed screening biomarkers, and emphasize the risks from premature clinical applications of unvalidated tests, all underscoring the need for new research strategies.

Comment on

PMID:
21372029
[PubMed - indexed for MEDLINE]
PMCID:
PMC3077065
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk